abrdn Healthcare Investors (HQH) is a publicly traded Financial Services sector company. As of May 21, 2026, HQH trades at $20.03 with a market cap of $1.13B and a P/E ratio of 0.00. HQH moved +1.83% today. Year to date, HQH is +6.95%; over the trailing twelve months it is +23.46%. Its 52-week range spans $13.77 to $20.46. Rallies surfaces HQH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in HQH news today?
abrdn Healthcare Investors Declares $0.63 Distribution With $18.08 Reinvestment Price: abrdn Healthcare Investors paid a $0.63 per share distribution on March 31, 2026, to shareholders of record as of February 20 with ex-dividend date February 20. Distributions were reinvested at $18.08 per share by default and comprised 100% net realized short-term capital gains.
DiMartino Rose bought 1.00K (~$18.88K) on Jul 16, 2024.
Goetz Kathleen bought 525 (~$8.62K) on Apr 9, 2024.
Reit Todd bought 1.00K (~$16.93K) on Jan 2, 2024.
HQH Analyst Consensus
HQH analyst coverage data. Average price target: $0.00.
Common questions about HQH
What changed in HQH news today?
abrdn Healthcare Investors Declares $0.63 Distribution With $18.08 Reinvestment Price: abrdn Healthcare Investors paid a $0.63 per share distribution on March 31, 2026, to shareholders of record as of February 20 with ex-dividend date February 20. Distributions were reinvested at $18.08 per share by default and comprised 100% net realized short-term capital gains.
Does Rallies summarize HQH news?
Yes. Rallies summarizes HQH news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is HQH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HQH. It does not provide personalized investment advice.
